These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 29122712)
21. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112 [TBL] [Abstract][Full Text] [Related]
22. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284 [TBL] [Abstract][Full Text] [Related]
23. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251 [TBL] [Abstract][Full Text] [Related]
24. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation. Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702 [TBL] [Abstract][Full Text] [Related]
25. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency. Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795 [TBL] [Abstract][Full Text] [Related]
26. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments. Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240 [TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
28. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Mustafa S; Devi VK; Pai RS Drug Deliv Transl Res; 2017 Feb; 7(1):27-36. PubMed ID: 27576453 [TBL] [Abstract][Full Text] [Related]
29. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies. Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858 [TBL] [Abstract][Full Text] [Related]
30. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595 [TBL] [Abstract][Full Text] [Related]
31. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738 [TBL] [Abstract][Full Text] [Related]
32. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575 [TBL] [Abstract][Full Text] [Related]
33. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies. Patil GB; Surana SJ J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812 [TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery. Yuan Z; Gu X Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633 [TBL] [Abstract][Full Text] [Related]
35. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs. Imanparast F; Faramarzi MA; Vatannejad A; Paknejad M; Deiham B; Kobarfard F; Amani A; Doosti M Microvasc Res; 2017 Jul; 112():14-19. PubMed ID: 28161429 [TBL] [Abstract][Full Text] [Related]
36. Formulation and optimization of doxorubicin loaded polymeric nanoparticles using Box-Behnken design: ex-vivo stability and in-vitro activity. Shaikh MV; Kala M; Nivsarkar M Eur J Pharm Sci; 2017 Mar; 100():262-272. PubMed ID: 28126560 [TBL] [Abstract][Full Text] [Related]
38. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential. Singh G; Pai RS Expert Opin Drug Deliv; 2014 May; 11(5):647-59. PubMed ID: 24661109 [TBL] [Abstract][Full Text] [Related]
39. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ Amin FU; Shah SA; Badshah H; Khan M; Kim MO J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812 [TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]